Sapient Capital’s Madison Square Garden MSGS Stock Holding History

Sapient Capital’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,696	Closed	-$8.25M	–	372
2024 Q1	$8.25M	Buy	+44,696	New	+$8.31M	0.18%	84

Other funds holding MSGS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Sapient Capital's MSGS Position: Q2 2024 in Review

Sapient Capital sold out of Madison Square Garden (MSGS) in Q2 2024, closing a stake of 44,696 shares — an estimated $8.25M sold.

Sapient Capital first reported a position in MSGS in Q1 2024 and held it in 1 quarter. The position peaked at $8.25M in Q1 2024. 307 funds tracked by Wall St. Rank hold MSGS as of Q2 2024.

Sapient Capital reported no remaining Madison Square Garden position as of Q2 2024 after selling out during the quarter.
Sapient Capital sold 44,696 Madison Square Garden shares in Q2 2024, an estimated $8.25M.
Sapient Capital first reported a position in Madison Square Garden in Q1 2024 and held it in 1 quarter.
Sapient Capital's Madison Square Garden position peaked at $8.25M in Q1 2024.
307 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2024.

Based on Sapient Capital's 13F filing for Q2 2024, filed 15 Jul 2024.